1. Home
  2. TVTX vs BLX Comparison

TVTX vs BLX Comparison

Compare TVTX & BLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • BLX
  • Stock Information
  • Founded
  • TVTX 2008
  • BLX 1977
  • Country
  • TVTX United States
  • BLX Panama
  • Employees
  • TVTX N/A
  • BLX N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • BLX Commercial Banks
  • Sector
  • TVTX Health Care
  • BLX Finance
  • Exchange
  • TVTX Nasdaq
  • BLX Nasdaq
  • Market Cap
  • TVTX 1.5B
  • BLX 1.7B
  • IPO Year
  • TVTX N/A
  • BLX N/A
  • Fundamental
  • Price
  • TVTX $24.64
  • BLX $45.02
  • Analyst Decision
  • TVTX Strong Buy
  • BLX
  • Analyst Count
  • TVTX 16
  • BLX 0
  • Target Price
  • TVTX $35.20
  • BLX N/A
  • AVG Volume (30 Days)
  • TVTX 2.7M
  • BLX 128.9K
  • Earning Date
  • TVTX 10-30-2025
  • BLX 10-28-2025
  • Dividend Yield
  • TVTX N/A
  • BLX 5.57%
  • EPS Growth
  • TVTX N/A
  • BLX 12.91
  • EPS
  • TVTX N/A
  • BLX 5.97
  • Revenue
  • TVTX $333,865,000.00
  • BLX $306,166,000.00
  • Revenue This Year
  • TVTX $83.87
  • BLX $16.94
  • Revenue Next Year
  • TVTX $40.99
  • BLX $6.18
  • P/E Ratio
  • TVTX N/A
  • BLX $7.54
  • Revenue Growth
  • TVTX 87.94
  • BLX 12.96
  • 52 Week Low
  • TVTX $12.91
  • BLX $31.14
  • 52 Week High
  • TVTX $28.69
  • BLX $48.38
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 59.38
  • BLX 39.81
  • Support Level
  • TVTX $23.22
  • BLX $44.61
  • Resistance Level
  • TVTX $25.10
  • BLX $47.36
  • Average True Range (ATR)
  • TVTX 1.27
  • BLX 0.84
  • MACD
  • TVTX -0.23
  • BLX -0.38
  • Stochastic Oscillator
  • TVTX 63.75
  • BLX 12.50

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About BLX Banco Latinoamericano de Comercio Exterior S.A.

Banco Latinoamericano de Comercio Exterior SA provides financial solutions to financial institutions, companies, and investors doing business in Latin America, supporting trade and regional integration. The Bank provides foreign trade solutions to a select client base of American financial institutions and corporations and has developed a network of correspondent banking institutions with access to the international capital markets. It has two business segments: the Commercial Business Segment and the Treasury Business Segment. The majority of its revenue is generated from the Commercial Business segment.

Share on Social Networks: